DK36889A - Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser - Google Patents

Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser

Info

Publication number
DK36889A
DK36889A DK036889A DK36889A DK36889A DK 36889 A DK36889 A DK 36889A DK 036889 A DK036889 A DK 036889A DK 36889 A DK36889 A DK 36889A DK 36889 A DK36889 A DK 36889A
Authority
DK
Denmark
Prior art keywords
medicine
prevention
preparation
treatment
cognitive disorders
Prior art date
Application number
DK036889A
Other languages
English (en)
Other versions
DK171094B1 (da
DK36889D0 (da
Inventor
Roman Amrein
Ravi Anand
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK36889D0 publication Critical patent/DK36889D0/da
Publication of DK36889A publication Critical patent/DK36889A/da
Application granted granted Critical
Publication of DK171094B1 publication Critical patent/DK171094B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK036889A 1988-01-28 1989-01-27 Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af cognitive lidelser DK171094B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH29888 1988-01-28
CH29888 1988-01-28

Publications (3)

Publication Number Publication Date
DK36889D0 DK36889D0 (da) 1989-01-27
DK36889A true DK36889A (da) 1989-07-29
DK171094B1 DK171094B1 (da) 1996-06-03

Family

ID=4183804

Family Applications (1)

Application Number Title Priority Date Filing Date
DK036889A DK171094B1 (da) 1988-01-28 1989-01-27 Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af cognitive lidelser

Country Status (15)

Country Link
US (1) US4906626A (da)
EP (1) EP0326023B1 (da)
JP (1) JPH07116043B2 (da)
KR (1) KR960016203B1 (da)
AT (1) ATE113207T1 (da)
AU (1) AU620584B2 (da)
CA (1) CA1332151C (da)
DE (1) DE58908544D1 (da)
DK (1) DK171094B1 (da)
ES (1) ES2063060T3 (da)
HU (1) HU203042B (da)
IE (1) IE65409B1 (da)
IL (1) IL89031A (da)
PH (1) PH26030A (da)
ZA (1) ZA89523B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751404T2 (de) * 1986-12-17 1995-12-21 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen.
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
JP3172202B2 (ja) * 1990-11-29 2001-06-04 エフ．ホフマン−ラ ロシュ アーゲー 不安の障害の処置剤
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
AU2004283452A1 (en) * 2003-10-23 2005-05-06 F. Hoffmann-La Roche Ag Benzazepine derivatives as MAO-B inhibitors
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
CA2628074C (en) 2005-10-25 2014-01-14 Shionogi & Co., Ltd. Aminodihydrothiazine derivative
JP5383484B2 (ja) * 2007-04-24 2014-01-08 塩野義製薬株式会社 環式基で置換されたアミノジヒドロチアジン誘導体
US8653067B2 (en) * 2007-04-24 2014-02-18 Shionogi & Co., Ltd. Pharmaceutical composition for treating Alzheimer's disease
KR101324426B1 (ko) * 2008-06-13 2013-10-31 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
CN102186841A (zh) * 2008-10-22 2011-09-14 盐野义制药株式会社 具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
MX2012006491A (es) 2009-12-11 2012-07-03 Shionogi & Co Derivados de oxazina.
EP2634188A4 (en) 2010-10-29 2014-05-07 Shionogi & Co FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
US8883779B2 (en) 2011-04-26 2014-11-11 Shinogi & Co., Ltd. Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
US10599006B2 (en) 2016-04-12 2020-03-24 E-Vision Smart Optics, Inc. Electro-active lenses with raised resistive bridges
ES2861520T3 (es) 2016-04-12 2021-10-06 E Vision Smart Optics Inc Lentes electroactivas con puentes resistivos elevados

Also Published As

Publication number Publication date
EP0326023A2 (de) 1989-08-02
IE65409B1 (en) 1995-10-18
HUT50042A (en) 1989-12-28
EP0326023B1 (de) 1994-10-26
ZA89523B (en) 1989-09-27
CA1332151C (en) 1994-09-27
IL89031A0 (en) 1989-08-15
ES2063060T3 (es) 1995-01-01
JPH07116043B2 (ja) 1995-12-13
PH26030A (en) 1992-01-29
AU2883689A (en) 1989-08-03
KR960016203B1 (ko) 1996-12-06
DE58908544D1 (de) 1994-12-01
JPH01224318A (ja) 1989-09-07
EP0326023A3 (en) 1990-09-05
AU620584B2 (en) 1992-02-20
DK171094B1 (da) 1996-06-03
DK36889D0 (da) 1989-01-27
IL89031A (en) 1995-07-31
US4906626A (en) 1990-03-06
IE890273L (en) 1989-07-28
KR890011589A (ko) 1989-08-21
HU203042B (en) 1991-05-28
ATE113207T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
DK36889A (da) Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
DE68929554D1 (de) Piperazinyl-substituierte Phenylpyrimidinderivative zur Behandlung oder Vorbeugung von ZNS Erkrankungen
DK0428038T3 (da) Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DE3686622D1 (de) Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen.
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
DK631989A (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
DK10188A (da) Middel til behandling af virussygdomme
ATE137408T1 (de) Verwendung von bärlauch zur therapie oder prophylaxe von durchblutungsstörungen
DE59010504D1 (de) Typisierung humaner Rhinoviren
ATE307587T1 (de) Verwendung von thiaminen zur herstellung eines arzneimittels zur prophylaxe und zur therapie der diabetischen retinopathie und der diabetischen nephropathie
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
FI890810A7 (fi) Palovammojen käsittely
BR9205712A (pt) Medicamento e processo para a preparaçao de um medicamento
DE68929177D1 (de) Verwendung von Dihydropyridinen zur Vorbeugung und Behandlung cerebraler Durchblutungsstörungen
DK163245C (da) Middel til behandling af neurologiske forstyrrelser eller lidelser
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DK621987D0 (da) Middel til forebyggelse eller behandling af kaelvningsfeber
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PUP Patent expired